Showing results (171-180 of 386) with videos related to

Sort By:
Pageof 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2025
First-in-Human Phase 1/2 Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid TumorsOmid Hamid, Dana B Cardin, F Stephen Hodi, et al.
Cancer Immunology Research|October 11, 2022
Hippo Signaling Pathway Regulates Cancer Cell-Intrinsic MHC-II ExpressionZexian Zeng, Shengqing Stan Gu, Nofal Ouardaoui, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 21, 2005
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901John D Roberts, Donna Niedzwiecki, William E Carson, et al.
British Journal of Cancer|July 6, 2016
Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancerVishwajith Sridharan, Danielle N Margalit, Stephanie A Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
KIT gene mutations and copy number in melanoma subtypesCarol Beadling, Erick Jacobson-Dunlop, F Stephen Hodi, et al.
Cancer Medicine|March 16, 2021
Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockadeElizabeth I Buchbinder, Jason L Weirather, Michael Manos, et al.
Cancer|March 1, 2014
Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitorsAllison Ackerman, Oliver Klein, David F McDermott, et al.
The Lancet. Oncology|March 30, 2012
Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trialKim Margolin, Marc S Ernstoff, Omid Hamid, et al.
Radiation Oncology (London, England)|June 24, 2014
The role of whole brain radiation therapy in the management of melanoma brain metastasesMichael A Dyer, Nils D Arvold, Yu-Hui Chen, et al.
Pageof 39